Thanks @1Abobo
I have written;
Resmed are tracking a cohort of over 0.5 million patients with prescriptions for both GLP-1 medications and positive airway pressure therapy.
Thanks for the reminder as I had forgotten they're now up to 660,000 patients in the cohort! Now that's what you call real world data analysis.
That funnel of RMD is only going to get larger and larger and that's not even factoring in what the smart watches tracking OSA market will bring into our funnel. Goodness me!
https://news.samsung.com/us/samsung-sleep-apnea-feature-galaxy-watch-first-its-kind-authorized-us-fda/
Cheers,
Tony
GLP-1 and OSA, page-88
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$29.90 |
Change
1.250(4.36%) |
Mkt cap ! $18.94B | |||
| Open | High | Low | Value | Volume |
| $29.38 | $29.90 | $29.28 | $56.93M | 1.920M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2798 | $29.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $29.91 | 9379 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |